BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 1506691)

  • 1. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation.
    Zhou W; Javors MA; Olson MS
    J Immunol; 1992 Sep; 149(5):1763-9. PubMed ID: 1506691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF-mediated platelet adhesion to endothelial cells induced by FMLP-stimulated leukocytes.
    Hirafuji M; Shinoda H
    J Lipid Mediat; 1991 Nov; 4(3):347-51. PubMed ID: 1662550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.
    Coëffier E; Joseph D; Prévost MC; Vargaftig BB
    Br J Pharmacol; 1987 Oct; 92(2):393-406. PubMed ID: 3118996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils.
    Shibata K; Yoshino H; Mizuno N; Shinohara H; Morita K; Kitayama S; Kurihara H; Dohi T
    Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):385-94. PubMed ID: 11060901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
    Zhou W; Javors MA; Olson MS
    Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP; McColl SR; Braquet P; Borgeat P
    Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism and regulation of neutrophil priming by platelet-activating factor.
    Gay JC
    J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes.
    Stewart AG; Harris T
    Lipids; 1991 Dec; 26(12):1044-9. PubMed ID: 1668104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H; Imanishi N; Natsume Y; Morooka S
    Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin).
    Chignard M; Selak MA; Smith JB
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8609-13. PubMed ID: 3464972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
    Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degree of neutrophil chemotaxis is dependent upon the chemoattractant and barrier.
    Casale TB; Abbas MK; Carolan EJ
    Am J Respir Cell Mol Biol; 1992 Jul; 7(1):112-7. PubMed ID: 1320901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization of acute inflammatory lesions to chemotaxins and endotoxin.
    Colditz IG; Movat HZ
    J Immunol; 1984 Oct; 133(4):2163-8. PubMed ID: 6088633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
    Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA; Wooten RE
    Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of reversible priming of human neutrophils using platelet-activating factor.
    Kitchen E; Rossi AG; Condliffe AM; Haslett C; Chilvers ER
    Blood; 1996 Dec; 88(11):4330-7. PubMed ID: 8943870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4.
    Dewald B; Baggiolini M
    Biochem Biophys Res Commun; 1985 Apr; 128(1):297-304. PubMed ID: 2985075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists.
    Palmantier R; Borgeat P
    Br J Pharmacol; 1991 Aug; 103(4):1909-16. PubMed ID: 1655146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.